Allegra Related Published Studies
Well-designed clinical trials related to Allegra (Fexofenadine)
Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine
on psychomotor function and histamine-induced wheal- and flare-responses: a
randomized double-blind, placebo-controlled study in healthy volunteers. [2012]
Intranasal phototherapy is more effective than fexofenadine hydrochloride in the treatment of seasonal allergic rhinitis: results of a pilot study. [2011.03]
The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans. [2011.02]
Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. [2011]
Effect of metronidazole on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy male volunteers. [2010.07]
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber. [2010.05]
Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS. [2010.04]
The effects of bilastine compared with cetirizine, fexofenadine, and placebo on
allergen-induced nasal and ocular symptoms in patients exposed to aeroallergen in
the Vienna Challenge Chamber. [2010]
Assessment of the antiobstructive effect of fexofenadine on nasal allergy challenge in patients with seasonal allergic rhinitis. [2009.12]
Effects of the P-glycoprotein inducer carbamazepine on fexofenadine pharmacokinetics. [2009.12]
Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers. [2009.06]
Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil. [2009.05]
Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy. [2009.03]
Bioequivalence of fexofenadine tablet formulations assessed in healthy Iranian volunteers. [2009]
Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit. [2009]
Fexofenadine effects on cognitive performance in aviators at ground level and simulated altitude. [2008.08]
Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis. [2007.12]
Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old. [2007.10]
The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. [2007.02]
Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare. [2007.01]
[The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial] [2006.11]
[Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial] [2006.11]
A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance. [2006.07]
Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis. [2006.05]
Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein. [2006.05]
Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis. [2006.04]
Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers. [2006.02]
Efficacy of fexofenadine in the prophylactic control of cat allergen-induced allergic rhinitis. [2006.02]
Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use. [2005.10]
Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma. [2005.09]
Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers. [2005.09]
Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism. [2005.08]
Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit. [2005.07]
Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration. [2005.07]
Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. [2005.06]
Comparative effects of fexofenadine and montelukast on allergen-induced wheal and flare. [2005.05]
Single-dose and steady-state bioequivalence of fexofenadine and pseudoephedrine combination tablets compared with individual formulations in healthy adults. [2005.05]
Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides. [2005.03]
Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season. [2005.02]
Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics. [2005.01]
Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination. [2005.01]
Similar rapid onset of action and magnitude of effect of fexofenadine and cetirizine as assessed by inhibition of histamine-induced wheal-and-flare reaction. [2004.12]
Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unit. [2004.09]
Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance. [2004.09]
Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. [2004.08]
Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies. [2004.06]
Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge. [2004.04]
Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis. [2004.04]
Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis. [2004.01]
Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. [2004.01]
Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria. [2004.01]
Comparative study of acute effects of single doses of fexofenadine, olopatadine, d-chlorpheniramine and placebo on psychomotor function in healthy volunteers. [2003.12]
Effect of the second-generation antihistamine, fexofenadine, on cough reflex sensitivity and pulmonary function. [2003.11]
A study comparing the inhibitory effects of single and repeated oral doses of ebastine and fexofenadine against histamine-induced skin reactivity. [2003.11]
Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis. [2003.10]
Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models. [2003.08]
The effects of fexofenadine on reaction time, decision-making, and driver behavior. [2003.08]
Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression. [2003.06]
Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. [2003.06]
H1-antihistaminic activity of cetirizine and fexofenadine in allergic children. [2003.06]
Supplementation of fexofenadine therapy with nedocromil sodium 2% ophthalmic solution to treat ocular symptoms of seasonal allergic conjunctivitis. [2003.06]
A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car. [2003.05]
Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention (TOVA). [2003.05]
The effects of acute doses of fexofenadine, promethazine, and placebo on cognitive and psychomotor function in healthy Japanese volunteers. [2003.04]
Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis. [2003.04]
The effects of single-dose fexofenadine, diphenhydramine, and placebo on cognitive performance in flight personnel. [2003.02]
Failure of cetirizine and fexofenadine to prevent motion sickness. [2003.02]
Effects of fexofenadine on the early response to nasal allergen challenge. [2002.12]
Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis. [2002.10]
Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge. [2002.07]
Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit. [2002.07]
[Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients] [2002.04.10]
A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. [2002.02]
An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers. [2002.01]
A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis. [2002.01]
Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. [2002.01]
Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state. [2002]
Lack of clinically relevant interaction between desloratadine and erythromycin. [2002]
[Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis] [2001.11]
Fexofenadine reduces nasal congestion in perennial allergic rhinitis. [2001.11]
Safety of fexofenadine in children treated for seasonal allergic rhinitis. [2001.07]
Twenty-four hours of activity of cetirizine and fexofenadine in the skin. [2001.04]
Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study. [2001.03]
Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast. [2001.01]
Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. [2000.07]
Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders. [2000.06]
Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. [2000.06]
Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. [2000.05]
Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. [2000.05]
Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. [2000.03.07]
Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine. [1999.11]
A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. [1999.11]
Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. [1999.11]
Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. [1999.10]
A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. [1999.08]
Cardiovascular safety of fexofenadine HCl. [1999.07]
A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects. [1999.07]
The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis. [1999.07]
Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen. [1999.06]
Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis. [1999.05]
Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers. [1998.12]
|
